Study ID: BDB-AS-101

Study Title

A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults

Teva Identifier

BDB-AS-101

ClinicalTrials.gov Identifier

NCT02030457

Study Status

Completed

Trial Condition(s)

Pharmacokinetics

Interventions

Drug: Beclomethasone dipropionate BAI | Drug: Beclomethasone dipropionate MDI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 45 Years

Trial Duration

12/01/2013 - 06/01/2014

Phase

Phase 1

Study Type

Interventional